As with lots of takeovers, it would have been better to sell on market than to accept the offer. In this case, higher price and much quicker payment.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025